Try HoloMonitor from a distance —
book your free live cell demo
!
Home
/
Investor Relati…
/
News
About
Our Story
To understand and cure the diseases that still plague humanity, medical science needs new tools.
Our Story
Background
Management and Board
Career
Partnerships
National Institute on Aging
Northeastern University
Huntsman Cancer Institute
UCSF
Gladstone Institutes
Lund University Cancer Centre
Malmö University
Uppsala University
Products
HoloMonitor
The HoloMonitor cell culture microscope non-invasively analyses cellular response and dynamic behavior in an …
HoloMonitor
Cell Imaging System
System Components
App Suite Cell Imaging Software
HoloLids
Technology
Gentle Live Cell Imaging
Quantitative Phase Imaging
Holographic Microscopy
Time-lapse Imaging Cytometry
Applications
Overview
Explore our range of live cell imaging applications and assays, circumventing the drawbacks of traditional …
Overview
Single-Cell Analysis
Cell QC
Cell Counter
Cell Proliferation
Cell Migration
Cell Motility and Migration
Cell Motility
Wound Healing
Dose Response
Cell Morphology
Cell Tracking
Publications
News
News and press releases.
News
Peer Reviewed Publications
Conference Papers and Posters
Doctoral Thesis
Resources
Webinars
We are happy to invite you to our series of live cell imaging webinars! Welcome to attend live, or view on demand …
Cell Videos & Tutorials
Brochures & Flyers
Application Notes
Manuals & Protocols
Webinars
Users
Blog
The Cell Cycle
Investor Relations
CEO Commentaries
CEO Peter Egelberg's blog, commenting PHI and medical science in general.
Introduktion
Bolagspresentation
Videopresentationer
CEO Commentaries
IR Contact
Stock Information
Reports & Documents
Investor Calendar
News
Contact
Book a Live Cell Imaging Demo
Book your live cell imaging demo of the incubator-based HoloMonitor cell culture microscope.
Contact PHI
Distributors
Contact IR
Book a Live Cell Imaging Demo
Shop
Webshop
Shop HoloMonitor products, applications and download the App Suite software.
Webshop
Cart
Checkout
My Account
Terms and Conditions
News
In English
September 28, 2020
Interim Report 1 (2020-05-01 – 2020-07-31)
The global COVID-19 restrictions have dramatically affected customers' ability to receive us for onsite demonstrations, installations and customer training. Despite this, several HoloMonitor units have been delivered since the beginning of the fiscal year in May.
September 2, 2020
PHI improves search engine ranking by enhancing website performance significantly
PHI improves website ranking by enhancing website performance significantly.
August 27, 2020
PHI granted patent on synthetic antibodies in the U.S.
PHI announces today that the Company has been granted a patent on synthetic antibodies from the United States Patent and Trademark Office.
June 25, 2020
Year-end Report 2019/20
To emerge stronger from the pandemic than entering it, we have for the time being focused our resources on reducing sales cost, improving our market visibility and expanding the HoloMonitor product line.
May 7, 2020
National Institute on Aging and PHI sign collaboration agreement
The National Institute on Aging and PHI recently entered a collaboration agreement, aiming to develop an add-on fluorescent module for PHI’s HoloMonitor imaging cytometer.
May 4, 2020
PHI secure working capital until 2022
To bridge and adapt to the consequences of the COVID-19 pandemic, PHI has received a binding credit facility of 15 MSEK.
1
2
3
…
13
In Swedish
October 10, 2019
Förslag till styrelse för Phase Holographic Imaging PHI AB
Inför årsstämman i Phase Holographic Imaging AB den 15 oktober föreslås omval av Maria Morin, Linda Neckmar, Johan Hyllner, Leland Foster, Mats Lundwall samt Jan Richardsson som ordinarie styrelseledamöter.
September 19, 2019
Årsredovisning 2018/19
Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2018 – 30 april 2019.
September 17, 2019
Kallelse till årsstämma i Phase Holographic Imaging PHI AB (publ)
Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542-7811, kallas härmed till årsstämma tisdagen den 15 oktober 2019 kl. 17.00 i bolagets lokaler, Scheelevägen 22 i Lund. Rätt att delta och anmälan Aktieägare som önskar delta i bolagsstämman ska vara införd i den av Euroclear Sweden AB förda aktieboken onsdagen den 9 oktober 2019, och …
June 11, 2019
Sista dag för handel med teckningsoptioner av serie TO 2
Idag, den 11 juni 2019, är sista dag för handel med teckningsoptioner av serie TO 2, vilka emitterades i samband med Phase Holographic Imaging PHI AB:s ("PHI") emission under sommaren 2018. Sista dag att teckna aktier med stöd av teckningsoptioner av serie TO 2 är den 13 juni 2019.
June 5, 2019
Intervju med VD Peter Egelberg
Med anledning av investerarträffen i Lund den 28 maj har Peter Egelberg, vd för Phase Holographic Imaging (PHI), idag en intervju i Biostock där han närmare förklarar innebörden av den senaste tidens pressmeddelanden gällande utvärderingsavtal med två större branschaktörer.
June 3, 2019
PHI ingår garantiavtal avseende teckning av TO 2
Lösenperioden för Phase Holographic Imaging:s (PHI) teckningsoptioner av serie TO 2 pågår för närvarande och avslutas den 13 juni 2019. PHI kan härmed meddela att en begränsad grupp större aktieägare ingått garantiåtagandeavtal med bolaget.
1
2
3
Latest CEO Commentaries
August 26, 2020
Probably, the fastest website in the world
The page you now are reading probably appeared faster on your screen than any other web page you have read.
March 31, 2020
Bridging Corona
As the dust from the stampede of bewildered politicians and overconfident billionaires settles, we begin to discern the new world shaped by the COVID-19 pandemic.
March 2, 2020
Joining forces with Huntsman
PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer. Using PHI's HoloMonitor technology, the researchers at Huntsman aim to develop methods quantifying the phenomena known as epithelial–mesenchymal transition (EMT).
View all commentaries